Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment.
Chen-Hua LiuChi-Yi ChenWei-Wen SuKuo-Chih TsengChing-Chu LoChun-Jen LiuJyh-Jou ChenCheng-Yuan PengYu-Lueng ShihSheng-Shun YangChia-Sheng HuangKe-Jhang HuangChi-Yang ChangMing-Chang TsaiWei-Yu KaoYo-Jen FangPo-Yueh ChenPei-Yuan SuChih-Wei TsengJow-Jyh HuangPei-Lun LeeHsueh-Chou LaiTsai-Yuan HsiehChung-Hsin ChangYi-Jie HuangFu-Jen LeeChun-Chao ChangJia-Horng KaoPublished in: Gut (2021)
SOF/VEL with or without low-dose RBV is effective and well-tolerated in HCV-infected patients with severe RI.